Hubert Czerniak - NIACYNA cz. 2 z 4 / Działanie / Nie uwierzycie, jak wielki wpływ ma na ORGANIZM!

Dr. William Kaufman treated osteoarthritis patients during the 1930s–40s, observing that both nicotinic acid and niacinamide reversed joint degeneration. He discovered that smaller, more frequent doses (e.g., 250 mg every 1.5–2 hours) were better tolerated and more effective than larger, less frequent ones. Patients regained joint mobility after about two months. Kaufman combined the niacinamide with vitamins C, B1, B2, A, and D3, and advocated dietary changes. He regarded osteoarthritis as a vitamin deficiency disease, specifically a niacinamide deficiency, and urged starting therapy as early as possible. The protocol was remarkably cheap and avoided all pharmaceutical anti-inflammatories. Czerniak notes that today such a protocol would likely result in a loss of medical license because it challenges the pharmaceutical paradigm.

Czerniak explains that sirtuins are a family of seven proteins located in mitochondria, cytoplasm, and nucleus, with profound effects on aging, cell death, fat metabolism, and resistance to viral and bacterial infections. They are naturally upregulated when caloric intake drops. The best method to achieve this is halving the eating window, which reduces overall calorie exposure and triggers sirtuin activation. As an alternative to time restriction, he mentions dietary polyphenols (resveratrol, catechins, etc.) that can also stimulate sirtuins. The protocol is positioned as a non-supplement, behavioral way to enhance the same NAD+-dependent pathways that niacin supports.

Czerniak provides an extensive list of foods that directly impact sirtuin activity, functioning as a dietary alternative or complement to time-restricted eating. The foods are drawn from various categories: spices (chili, turmeric), vegetables (kale, onion, celery), fruits (berries, dates), legumes (soy, buckwheat), beverages (coffee, green tea, red wine, cocoa) and nuts (walnuts). He explains that these polyphenols not only activate sirtuins but also have independent antioxidant and anti-inflammatory effects. He contrasts this natural approach with pharmaceutical drugs, implying that a polyphenol-rich diet is a safe, multifunctional anti-aging tool that modern medicine ignores.

Czerniak uses the example of cystathionine synthase deficiency, a genetic mutation that blocks the conversion of homocysteine to cysteine, causing skeletal defects, vascular abnormalities, and lens dislocation. These individuals exhibit high homocysteine, which triggers elevated cholesterol, atherosclerosis, and enlarged red blood cells (macrocytosis) leading to tissue hypoxia. Up to 50% of such cases can be treated with high-dose vitamin B6. He generalizes that any high homocysteine scenario points to insufficiencies of B6, B12, B9, B2, or B1, and that correcting these deficiencies can lower homocysteine and reduce cardiovascular risk. This approach is presented as an obvious, low-cost intervention that is often overlooked in favor of statins.

Czerniak explains that the HIV virus deliberately depletes the body of selenium, glutamine, cysteine, and tryptophan—the building blocks of the selenoenzyme glutathione peroxidase. Without this enzyme, oxidative stress overwhelms immune cells, driving the disease progression. He states that providing these nutrients can reverse the symptoms, and that early supplementation can prevent symptoms from appearing at all. This is another example of how specific nutrient deficiencies underpin severe disease, and how tailored supplementation can intervene, paralleling his earlier arguments about niacin.

Czerniak presents animal research showing that vitamin-depleted mice exhibited excessive running behavior (hyperkinesis), while niacin administration reduced it. He extends this to children with ADHD, noting that Ritalin (methylphenidate) is associated with cancer in animal studies, bans US military enrollment, and is linked to a 17,500 increase in childhood heart disease. By contrast, niacin is a natural precursor to NAD+ that addresses an underlying nutritional deficit, offering a safer alternative. This is part of his larger thesis that many neuropsychiatric disorders are manifestations of chronic niacin deficiency.

Czerniak recounts Kaufman's work showing that osteoarthritis responded dramatically to niacinamide, with a regimen of small, frequent doses improving joint mobility within two months. He extends this by citing animal experiments where niacin reduced hyperactivity and compulsive behaviors, suggesting ADHD is partly a B3 deficiency. The condition pelagra itself was often misdiagnosed as schizophrenia; niacin challenge could distinguish them—rapid improvement indicated pellagra, while slower response required higher doses and longer treatment for schizophrenia. He asserts that people with genetically higher needs cannot meet their B3 requirements through diet alone and must supplement, and that even the best diet delivers less than 100 mg of niacin per day, far below therapeutic levels. The connection to autoimmunity is drawn through the IDO enzymatic pathway: niacin-derived NAD+ influences tryptophan metabolism, producing immunosuppressive metabolites that calm hyperactive immune responses in conditions like Hashimoto’s, asthma, and rheumatoid arthritis. This re-frames niacin as a foundational nutritional intervention for a spectrum of otherwise drug-managed illnesses.

He contrasts the withdrawal and potential re-introduction of Vioxx (a COX-2 inhibitor) with a black-box 'use may cause death' warning, despite its link to 70,000 cardiac deaths, against the strict limits on vitamin dosages that are hundreds of times below safe clinical levels. The disparity, he argues, arises because the FDA collects a percentage of drug sales, aligning its financial interest with pharmaceutical companies. This same mechanism, he implies, explains why doctors using innovative vitamin protocols lose their medical licenses while drugs that caused a 17,500 increase in childhood heart disease are marketed. The double standard is illustrated by the example of Ritalin for ADHD: it is actively promoted, yet animal studies show it induces cancer and it carries a stigma that disqualifies users from US military service. This ‘regulatory capture’ narrative recasts the entire medical orthodoxy as economically corrupt and hostile to low-cost nutritional solutions.

Czerniak introduces this fact as a capstone to his discussion of NAD+, sirtuins, and PARP—all of which depend on niacin-derived NAD+ for DNA repair and genomic stability. The 5% longer telomeres observed in supplementing women is presented as direct human evidence that maintaining optimal vitamin levels, including niacin, mitigates cellular aging. He ties this back to the necessity of supplementation, implying that the population-wide decline in dietary niacin and other micronutrients is accelerating biological aging. The precise supplement regimen is not specified, but the broader point is that vitamins play a causal role in telomere preservation, likely through enhanced NAD+ availability for sirtuin-mediated chromatin silencing and PARP-mediated DNA damage repair.